Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery

✍ Scribed by M. Carrier; P. Ménasché; J.H. Levy; M.F. Newman; K.M. Taylor; A. Haverich; J.C. Chen; S.K. Shernan; F. Van de Werf; M. van der Laan; T.G. Todaro; P.X. Adams; E.D. Verrier

• Book ID: 113760567
• Publisher: CTSNet
• Year: 2006
• Tongue: English
• Weight: 129 KB
• Volume: 131
• Category: Article
• ISSN: 1097-685X
• DOI: 10.1016/j.jtcvs.2005.10.011